We are live on ! Find out more

18 hedge funds and large institutions have $513K invested in Imunon in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.44%0.43% (-0.01%)

10% less capital invested

Capital invested by funds: $573K → $513K (-$59.5K)

14% less funds holding

Funds holding: 2118 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q1 2023 in Review

18 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2023, worth a combined $513K — down 10% from $573K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of IMNN and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $94.1K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $83.3K sold.

  • 18 institutional investors held Imunon (IMNN) as of Q1 2023, down from 21 in Q4 2022.
  • Funds reported $513K of Imunon stock for Q1 2023, down 10% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q1 2023 and 7 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q1 2023 was Citadel Advisors, an estimated $94.1K added.
  • The largest Imunon seller in Q1 2023 was Two Sigma Advisers, an estimated $83.3K sold.

Based on aggregated 13F filings for Q1 2023.